Company: LNAI
Filing Date: 2025-02-18
Form Type: NT 10-Q
Source: 0001731122-25-000241
Chunk: 2

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-18
Form: NT 10-Q
Chunk 2
---
 at December 31, 2024.                                                                    |
| ● | Accumulated deficit increased from $332,455,081 at June 30, 2024 to $383,919,510 at December 31, 2024.                                                                           |
| ● | Other comprehensive income (loss) increased from ($170,846) at June 30, 2024 to ($3,847,603) at December 31, 2024.                                                               |
| ● | General and administrative expenses increased from $3,616,392 for the three months ended December 31, 2023 to $4,353,123 for the three months ended December 31, 2024.           |
| ● | General  and administrative expenses decreased from $11,906,602 for the six months ended December 31, 2023 to $9,654,373 for the six months ended December 31 2024.              |
| ● | Research and development expenses decreased from $620,521 for the three months ended December 31, 2023 to $161,084 for the three months ended December 31, 2024.                 |
| ● | Research  and development expenses decreased from $1,187,165 for the six months ended December 31, 2023 to $551,273 for the six months ended December 31, 2024.                  |
| ● | Goodwill impairment expenses increased from zero for the six months ended December 31, 2023 to $47,614,729 for the six months ended December 31, 2024.                           |
| ● | Loss on extinguishment of debt decreased from $(120,018) for the six months December 31, 2023 to zero for the six months ended December 31, 2024.                                |
| ● | Change in fair value of contingent consideration increased from zero for the three months ended December 31, 2023 to $($2,590,000) for the three months ended December 31, 2024. |
| ● | Change in fair value of contingent consideration increased from zero for the six months ended December 31, 2023 to $6,660,000 for the six months ended December 31, 2024.        |

The amounts reported above are still under review by the Registrant’s
independent registered public accounting firm and accounting staff and may differ once reported in the Form 10-Q to be filed by the Registrant.

<div align='